Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Paradigm Biopharmaceuticals Ltd.
Paradigm Doses First US Subjects under Phase 3 trial
Business
Apr 28 2022
3 min read

Paradigm Doses First US Subjects under Phase 3 trial

news images

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment